Page results
-
UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.
-
Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains, according to laboratory findings from UCLH and the Francis Crick Institute.
-
A critical care nurse at The National Hospital for Neurology and Neurosurgery, Helen Burgess, has produced a short film to provide reassurance to relatives unable to visit their loved ones because of visitor restrictions during the Covid-19 pandemic.
-
The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.
-
In May 2020, UCLH invited acclaimed photographer Tom Pilston to take portraits of staff at the height of the Covid-19 pandemic.
-
To mark World Cancer Day 2025, UCLH is announcing that it is expanding research into cell therapies for solid tumours.
-
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
-
Martin Jacobs joined UCLH as a non-executive director on 1 January 2020. He spent 20 years with PricewaterhouseCoopers (PwC) where he was a Partner within the Corporate Finance division.
-
Patient information for patients suffering from long COVID who are trying to return to physical activity,
-
Dr Junaid Bajwa became a non-executive director at UCLH in September 2018. He was born at UCLH and is a practising GP with experience of serving a deprived London community.
File results
-
FOI/2024/0540 - Contact details of Clinical Governance lead
-
FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes
-
FOI/2024/0372 - Contact details of e-learning department
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0376 - Advice provided on topical medication for eczema patients
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0386 - Stonewall funding for 2022/23-2023/24
-
FOI/2024/0391 - Hospital admissions due to psychedelics consumption
-
FOI/2024/0404 - Senior HR/ Workforce staff contact details